Oncology Learning Network

Oncology Learning Network Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Oncology Learning Network, East Windsor, NJ.

Oncology Learning Network® is an online resource for the latest developments in oncology practice, providing a customized experience for readers to stay informed about the topics that matter most to them.

09/10/2026

How should PSMA PET findings shape disease-volume assessment and treatment intensification in metastatic prostate cancer? After progression on an androgen receptor pathway inhibitor in PSMA-positive metastatic castration-resistant prostate cancer, how should clinicians sequence lutetium-177 PSMA radioligand therapy and chemotherapy?

Dr. Scott Tagawa and Dr. Atish Choudhury examine two distinct areas of uncertainty in prostate cancer care and explain why these evolving questions matter for treatment selection.

Explore more of the clinical questions being debated at OLN Great Debates in Solid Tumors, September 26–27 in New York.

View the full agenda: https://hubs.ly/Q04x9gBL0

OLN Great Debates in Solid Tumors is less than three weeks away, and we’re proud to welcome an outstanding group of loca...
09/10/2026

OLN Great Debates in Solid Tumors is less than three weeks away, and we’re proud to welcome an outstanding group of local faculty to the program.

These New York-area experts from Memorial Sloan Kettering Cancer Center, Mount Sinai Health System, NYU Langone Health, Weill Cornell Medicine, and Northwell Health Cancer Center will join colleagues from across the country to debate the clinical questions shaping solid tumor care.

See them take the stage September 26–27 in New York City.

Learn more about the debates: https://hubs.ly/Q04x89_T0

Through diagnosis. Through treatment. Together.Prostate cancer affects more than the person diagnosed. Families, caregiv...
09/10/2026

Through diagnosis. Through treatment. Together.

Prostate cancer affects more than the person diagnosed. Families, caregivers, and healthcare professionals share in the journey through treatment, recovery, and survivorship.

This Prostate Cancer Awareness Month, we recognize every person affected and every partner in care who continues alongside them.

The Rising Stars Fellows Program is almost here! On Friday, September 25th in New York City, lung cancer oncology fellow...
09/01/2026

The Rising Stars Fellows Program is almost here! On Friday, September 25th in New York City, lung cancer oncology fellows will gather for a half-day of sessions on medical communications, clinical thought leadership, network building, establishing digital presence and expertise, and career development ahead of OLN Great Debates in Solid Tumors. Faculty include Jamie Chaft, MD; Edward Garon, MD, MS; Julia Rotow, MD; and Eric Singhi, MD.

The program is free. Spots are limited. Do not wait to apply. https://hubs.ly/Q04q08_h0

Please note: Rising Stars requires a separate application and is not included with OLN Great Debates registration. Participation in Rising Stars does not register you for OLN Great Debates, and OLN Great Debates registration does not include participation in Rising Stars.

One month away. Have you registered yet? The Rising Stars Fellows Program is a free, one-day workshop on Friday, Septem...
08/25/2026

One month away. Have you registered yet?

The Rising Stars Fellows Program is a free, one-day workshop on Friday, September 25th in New York City, designed for oncology fellows with a focused interest in lung cancer. The agenda includes five dedicated sessions led by Jamie Chaft, MD; Edward Garon, MD, MS; Julia Rotow, MD; and Eric Singhi, MD, covering communications, leadership, networking, and digital presence.

Space is limited and this program is filling quickly. Apply for free now: https://hubs.ly/Q04vbyxv0

Your digital presence is part of your professional identity, and it is something you can build intentionally. Eric Sing...
08/20/2026

Your digital presence is part of your professional identity, and it is something you can build intentionally.

Eric Singhi, MD, will lead a session on becoming a digital opinion leader at the Rising Stars Fellows Program on September 25th. His session will explore how fellows can use social media, online platforms, and digital communication to share expertise, engage the oncology community, and grow their influence in the field.

This is one of five sessions on the Rising Stars agenda designed to help fellows step into leadership roles earlier in their careers. Apply here: https://hubs.ly/Q04q0frC0

08/14/2026

When a patient is sitting in front of us, are we asking about both the patient’s germline alterations and the somatic alterations in the tumor?

These findings may provide prognostic and predictive information and identify matched treatment options. Yet not every patient is being tested.

Scott Tagawa, MD, MS, addresses a fundamental question in precision oncology and the testing gap that can limit informed treatment decisions.

Watch his perspective and join the clinical discussions at OLN Great Debates in Solid Tumors, September 26–27 in New York City.

https://bit.ly/4qaFVId

The Rising Stars Fellows Program on September 25th gives lung cancer oncology fellows a structured, faculty-led day befo...
08/12/2026

The Rising Stars Fellows Program on September 25th gives lung cancer oncology fellows a structured, faculty-led day before OLN Great Debates in Solid Tumors kicks off. The agenda covers five core areas: medical communications and presentation skills, the role of clinical thought leaders, network building, becoming a digital opinion leader, and career development in oncology.

Fellows will leave with actionable takeaways, new relationships, and a stronger foundation for the road ahead. Apply to attend today! https://hubs.ly/Q04q0cHh0

Please note: Rising Stars requires a separate application and is not included with OLN Great Debates registration. Participation in Rising Stars does not register you for OLN Great Debates, and OLN Great Debates registration does not include participation in Rising Stars.

Oral SERDs may share a mechanism, but the data do not necessarily answer whether they should be used interchangeably.How...
08/11/2026

Oral SERDs may share a mechanism, but the data do not necessarily answer whether they should be used interchangeably.

How much weight should clinicians give to differences in ESR1-mutated disease, tolerability, pharmacology, combination potential, and sequencing? And are those distinctions meaningful enough to influence treatment selection?

At OLN Great Debates in Solid Tumors, Seth Wander, MD, PhD, of Massachusetts General Hospital and Karthik Giridhar, MD, of Mayo Clinic will examine both sides of this evolving breast cancer question.

Learn more about the debates: https://bit.ly/3RGGYmi

08/06/2026

What do you do when the data supports more than one defensible treatment approach?

Across breast, lung, genitourinary, and gynecologic cancers, clinicians are navigating questions that remain unsettled:

• Should an emerging ESR1 mutation detected through ctDNA prompt a treatment change before radiographic progression?
• Is additional therapy necessary after a pathologic complete response to neoadjuvant chemoimmunotherapy?
• Should chemotherapy or lutetium-177 PSMA come next after progression on an androgen receptor pathway inhibitor?
• How should molecular profiling inform treatment for low-grade serous ovarian carcinoma?

Sara Nunnery, MD, MSI; Estelamari Rodriguez, MD, MPH; Atish Choudhury, MD, PhD; and Jubilee Brown, MD, explain why these decisions require closer examination of the evidence, patient burden, toxicity, and unanswered questions.

Watch the video, then join the debates September 26–27 in New York City.
https://bit.ly/4fvyOGu

Address

East Windsor, NJ

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 4:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Website

Alerts

Be the first to know and let us send you an email when Oncology Learning Network posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share